Kenya Infectious Disease Drugs Market Analysis

Kenya Infectious Disease Drugs Market Analysis

$ 3999

Kenya Infectious Disease Drugs Market valued at $83.12 Mn in 2023, projected to reach $119.88 Mn by 2030 with a 5.37% CAGR. The market is expanding due to government initiatives, rising awareness and education, and the prevalence of infectious diseases. The market is dominated by key players like Novartis, GlaxoSmithKline plc, AbbVie Inc., Merck & Co., F. Hoffman-La Roche Ltd., Abbott Laboratories, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Pfizer, and Sanofi.

ID: IN10KEPH012 CATEGORY: Pharmaceuticals GEOGRAPHY: Kenya AUTHOR: Aneri Parekh

Buy Now

Kenya Infectious Disease Drugs Market Executive Summary

Kenya Infectious Disease Drugs Market valued at $83.12 Mn in 2023, projected to reach $119.88 Mn by 2030 with a 5.37% CAGR.

Kenya's market for infectious disease drugs is centered on the development, manufacturing, distribution, and use of pharmaceuticals for the avoidance and management of infectious diseases in the country. It addresses common illnesses like HIV/ AIDS, malaria, tuberculosis, and respiratory infections. It includes a variety of treatment areas, such as antiviral, antibiotic, antifungal, and antiparasitic medications. This market is essential to preserving public health, advancing healthcare programs, and reducing the prevalence of infectious diseases in Kenya.

The high prevalence of infectious diseases like HIV/ AIDS, malaria, tuberculosis, and respiratory infections characterizes Kenya's infectious disease drugs market. Multinational pharmaceutical corporations and regional producers are important participants in the market, with an emphasis on offering accessible and reasonably priced treatment alternatives. To enhance population health outcomes, government programs, global alliances, and rising healthcare expenditures propel market expansion.

The global market for drugs utilized for treating infectious diseases was estimated to be worth $118.75 Bn in 2023. Both a rise in diagnosis and government-sponsored public education initiatives regarding the treatment and prevention of infectious diseases have been attributed to this spike. The increasing level of generic competition is indicative of a changing market situation. Removing financial obstacles and expanding access to therapy are necessary for long-term progress, especially in developing nations. This will lead to more industrial research and development.

Global pharmaceutical giant GSK is well-known in Kenya's market for medications used to treat infectious diseases. Major infectious diseases in Kenya, such as HIV/ AIDS, malaria, tuberculosis, and neglected tropical diseases (NTDs), are among the top priorities for GSK's research and development efforts. With a local office and a team committed to meeting Kenya's healthcare needs, GSK is present in the nation. They work together with regional partners to comprehend the unique requirements and obstacles faced by the Kenyan populace and then modify their initiatives accordingly.

Kenya infectious disease drugs market

Market Dynamics

Market Growth Drivers:

Rising Prevalence of Infectious Diseases: An increase in the frequency of infectious diseases due to urbanization, population growth, and a poor healthcare system drive the market.

Government Initiatives: Governmental efforts and financial commitments to disease prevention and healthcare facilities and enhancing public knowledge and education on infectious diseases raise demand for the market.

Technological Advancements: the market is propelling due to improvements in infectious disease management, diagnosis, and treatment brought about by technological breakthroughs.

Market Restraints:

Prevalence of Counterfeit Drugs: The prevalence of counterfeit drugs in the Kenyan market presents a serious obstacle that diminishes confidence in genuine medications and hinders investment in the sector.

Obstacles in Vaccine Delivery and Storage: In resource-constrained environments like Kenya, maintaining the cold chain infrastructure for some vaccines can be difficult, and inadequate storage temperatures can make vaccines ineffective, impeding the success of immunization programs and affecting the growth of the market.

High Cost: The high expense of medications for infectious diseases limits many patients' access and affordability, slowing the growth of the market.

Healthcare Policies and Regulatory Landscape

The Pharmacy and Poisons Board (PPB) was created as the Drug Regulatory Authority by the Pharmacy and Poisons Act, Chapter 244 of the Kenyan Laws. The Board is in charge of regulating the production, distribution, and use of poisons and medications, as well as pharmacy practice. PPB assesses applications and product samples for quality, safety, and efficacy. The samples are thoroughly analyzed by three labs. Fast-track options are available for certain medications, potentially reducing the usual six- to one-year waiting period by several months. Ensuring that Kenyan people have access to reasonably priced, high-quality healthcare is the PPB's ultimate goal. The approval procedure itself could be a tedious and bureaucratic one, characterized by delays caused by unclear specifications, missing paperwork, and irregularities within the PPB.

Competitive Landscape

Key Players:

  • Novartis
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Merck & Co.
  • F. Hoffman-La Roche Ltd.
  • Abbott Laboratories
  • Boehringer Ingelheim International GmbH
  • Janssen Pharmaceuticals
  • Pfizer
  • Sanofi

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Infectious Disease Drug Market Segmentation

By Disease

  • HIV
  • Influenza
  • Hepatitis
  • Tuberculosis
  • Malaria
  • Other

By Treatment

  • Antibacterial
  • Antiviral
  • Antiparasitic
  • Other

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 12 March 2024
Updated by: Shivam Zalke

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter